http://www.odeo.com/channels/31671-NEJM-Interviews-with-PDF NEJM no The New England Journal of Medicine (NEJM) Audio interview RSS feed. A PDF of the associated article is included. NEJM (http://www.nejm.org) is a weekly general medical journal that publishes new medical research findings, review articles, and editorial opinion on a wide variety of topics of importance to biomedical science and clinical practice. The New England Journal of Medicine (NEJM) Audio interview RSS feed. A PDF of the associated article is included. NEJM (http://www.nejm.org) is a weekly general medical journal that publishes new medical research findings, review articles, and editorial opinion on a wide variety of topics of importance to biomedical science and clinical practice. The New England Journal of Medicine (NEJM) Audio interview RSS feed. A PDF of the associated article is included. NEJM (http://www.nejm.org) is a weekly general medical journal that publishes new medical research findings, review articles, and editorial opinion on a wide variety of topics of importance to biomedical science and clinical practice. en-US 40 Wed, 27 Aug 2008 08:01:00 -0700 Wed, 27 Aug 2008 08:01:00 -0700 Medicine http://www.odeo.com/episodes/23221596-NEJM-Interview-Anthony-Fauci-on-the-challenges-and-prospects-of-an-HIV-vaccine Anthony Fauci is the director of the National Institute of Allergy and Infectious Diseases, Bethesda, MD. Teresa Schraeder, the interviewer, is a clinical assistant professor at the Warren Alpert Medical School of Brown University, Providence, RI. Supplement to: Johnston MI and Fauci AS. An HIV Vaccine - Challenges and Prospects. N Engl J Med 2008;359:888-90. Anthony Fauci is the director of the National Institute of Allergy and Infectious Diseases, Bethesda, MD. Teresa Schraeder, the interviewer, is a clinical assistant professor at the Warren Alpert Medical School of Brown University, Providence, RI. Supplement to: Johnston MI and Fauci AS. An HIV Vaccine - Challenges and Prospects. N Engl J Med 2008;359:888-90. Anthony Fauci is the director of the National Institute of Allergy and Infectious Diseases, Bethesda, MD. Teresa Schraeder, the interviewer, is a clinical assistant professor at the Warren Alpert Medical School of Brown University, Providence, RI. Supplement to: Johnston MI and Fauci AS. An HIV Vaccine - Challenges and Prospects. N Engl J Med 2008;359:888-90. tag:odeo.com,2008-08-27,23221596 Wed, 27 Aug 2008 08:01:00 -0700 no NEJM Interviews with PDF http://www.odeo.com/episodes/23221597-Perspective-PDF-An-HIV-Vaccine-Challenges-and-Prospects Now well into the third decade of the pandemic of HIV and AIDS, we have seen dramatic successes in the treatment of HIV-infected persons in the United States and many other countries. Yet the pandemic still rages. Now well into the third decade of the pandemic of HIV and AIDS, we have seen dramatic successes in the treatment of HIV-infected persons in the United States and many other countries. Yet the pandemic still rages. Now well into the third decade of the pandemic of HIV and AIDS, we have seen dramatic successes in the treatment of HIV-infected persons in the United States and many other countries. Yet the pandemic still rages. tag:odeo.com,2008-08-27,23221597 Wed, 27 Aug 2008 08:00:00 -0700 no NEJM Interviews with PDF http://www.odeo.com/episodes/23130883-NEJM-Interview-Wafaa-El-Sadr-on-the-successes-and-shortcomings-of-PEPFAR-s-efforts-to-address-the-HIV-epidemic-in-the-developing-world Wafaa El-Sadr is the director of the International Center for AIDS Care and Treatment Programs and a professor of clinical medicine and epidemiology at Columbia University, New York. Rachel Gotbaum is an independent producer based in Boston. Supplement to: El-Sadr WM and Hoos D. The President's Emergency Plan for AIDS Relief -- Is the Emergency Over? N Engl J Med 2008;359:553-5. Wafaa El-Sadr is the director of the International Center for AIDS Care and Treatment Programs and a professor of clinical medicine and epidemiology at Columbia University, New York. Rachel Gotbaum is an independent producer based in Boston. Supplement to: El-Sadr WM and Hoos D. The President's Emergency Plan for AIDS Relief -- Is the Emergency Over? N Engl J Med 2008;359:553-5. Wafaa El-Sadr is the director of the International Center for AIDS Care and Treatment Programs and a professor of clinical medicine and epidemiology at Columbia University, New York. Rachel Gotbaum is an independent producer based in Boston. Supplement to: El-Sadr WM and Hoos D. The President's Emergency Plan for AIDS Relief -- Is the Emergency Over? N Engl J Med 2008;359:553-5. tag:odeo.com,2008-07-30,23130883 Wed, 30 Jul 2008 08:01:00 -0700 no NEJM Interviews with PDF http://www.odeo.com/episodes/23130885-NEJM-Interview-Allan-Brandt-discusses-the-provisions-benefits-and-criticisms-of-legislation-that-would-grant-the-FDA-regulatory-authority-over-tobacco-products Allan Brandt is a professor of the history of medicine at Harvard Medical School, Boston, and dean of the graduate school of arts and sciences at Harvard University, Cambridge, MA. Teresa Schraeder, the interviewer, is an internist and medical journalist. Supplement to: Brandt AM. FDA Regulation of Tobacco -- Pitfalls and Possibilities. N Engl J Med 2008;359:445-8. Allan Brandt is a professor of the history of medicine at Harvard Medical School, Boston, and dean of the graduate school of arts and sciences at Harvard University, Cambridge, MA. Teresa Schraeder, the interviewer, is an internist and medical journalist. Supplement to: Brandt AM. FDA Regulation of Tobacco -- Pitfalls and Possibilities. N Engl J Med 2008;359:445-8. Allan Brandt is a professor of the history of medicine at Harvard Medical School, Boston, and dean of the graduate school of arts and sciences at Harvard University, Cambridge, MA. Teresa Schraeder, the interviewer, is an internist and medical journalist. Supplement to: Brandt AM. FDA Regulation of Tobacco -- Pitfalls and Possibilities. N Engl J Med 2008;359:445-8. tag:odeo.com,2008-07-30,23130885 Wed, 30 Jul 2008 08:01:00 -0700 no NEJM Interviews with PDF http://www.odeo.com/episodes/23197808-NEJM-Interview-Wafaa-El-Sadr-on-the-successes-and-shortcomings-of-PEPFAR-s-efforts-to-address-the-HIV-epidemic-in-the-developing-world Wafaa El-Sadr is the director of the International Center for AIDS Care and Treatment Programs and a professor of clinical medicine and epidemiology at Columbia University, New York. Rachel Gotbaum is an independent producer based in Boston. Supplement to: El-Sadr WM and Hoos D. The President's Emergency Plan for AIDS Relief -- Is the Emergency Over? N Engl J Med 2008;359:553-5. Wafaa El-Sadr is the director of the International Center for AIDS Care and Treatment Programs and a professor of clinical medicine and epidemiology at Columbia University, New York. Rachel Gotbaum is an independent producer based in Boston. Supplement to: El-Sadr WM and Hoos D. The President's Emergency Plan for AIDS Relief -- Is the Emergency Over? N Engl J Med 2008;359:553-5. Wafaa El-Sadr is the director of the International Center for AIDS Care and Treatment Programs and a professor of clinical medicine and epidemiology at Columbia University, New York. Rachel Gotbaum is an independent producer based in Boston. Supplement to: El-Sadr WM and Hoos D. The President's Emergency Plan for AIDS Relief -- Is the Emergency Over? N Engl J Med 2008;359:553-5. tag:odeo.com,2008-07-30,23197808 Wed, 30 Jul 2008 08:01:00 -0700 no NEJM Interviews with PDF http://www.odeo.com/episodes/23197810-NEJM-Interview-Allan-Brandt-discusses-the-provisions-benefits-and-criticisms-of-legislation-that-would-grant-the-FDA-regulatory-authority-over-tobacco-products Allan Brandt is a professor of the history of medicine at Harvard Medical School, Boston, and dean of the graduate school of arts and sciences at Harvard University, Cambridge, MA. Teresa Schraeder, the interviewer, is an internist and medical journalist. Supplement to: Brandt AM. FDA Regulation of Tobacco -- Pitfalls and Possibilities. N Engl J Med 2008;359:445-8. Allan Brandt is a professor of the history of medicine at Harvard Medical School, Boston, and dean of the graduate school of arts and sciences at Harvard University, Cambridge, MA. Teresa Schraeder, the interviewer, is an internist and medical journalist. Supplement to: Brandt AM. FDA Regulation of Tobacco -- Pitfalls and Possibilities. N Engl J Med 2008;359:445-8. Allan Brandt is a professor of the history of medicine at Harvard Medical School, Boston, and dean of the graduate school of arts and sciences at Harvard University, Cambridge, MA. Teresa Schraeder, the interviewer, is an internist and medical journalist. Supplement to: Brandt AM. FDA Regulation of Tobacco -- Pitfalls and Possibilities. N Engl J Med 2008;359:445-8. tag:odeo.com,2008-07-30,23197810 Wed, 30 Jul 2008 08:01:00 -0700 no NEJM Interviews with PDF http://www.odeo.com/episodes/23130884-Perspective-PDF-The-President-s-Emergency-Plan-for-AIDS-Relief-Is-the-Emergency-Over On July 16, the Senate approved legislation that would increase the funding for the President’s Emergency Plan for AIDS Relief (PEPFAR) to $48 billion for the next 5 years. Drs. Wafaa El-Sadr and David Hoos examine PEPFAR’s achievements, limitations, and lessons for the future. On July 16, the Senate approved legislation that would increase the funding for the President’s Emergency Plan for AIDS Relief (PEPFAR) to $48 billion for the next 5 years. Drs. Wafaa El-Sadr and David Hoos examine PEPFAR’s achievements, limitations, and lessons for the future. On July 16, the Senate approved legislation that would increase the funding for the President’s Emergency Plan for AIDS Relief (PEPFAR) to $48 billion for the next 5 years. Drs. Wafaa El-Sadr and David Hoos examine PEPFAR’s achievements, limitations, and lessons for the future. tag:odeo.com,2008-07-30,23130884 Wed, 30 Jul 2008 08:00:00 -0700 no NEJM Interviews with PDF http://www.odeo.com/episodes/23130886-Perspective-PDF-FDA-Regulation-of-Tobacco-Pitfalls-and-Possibilities It is likely that during the coming year, Congress will pass legislation bringing tobacco products under the regulatory authority of the FDA. Allan Brandt writes that it behooves public health advocates and Congress to fully understand all the implications of FDA regulation. It is likely that during the coming year, Congress will pass legislation bringing tobacco products under the regulatory authority of the FDA. Allan Brandt writes that it behooves public health advocates and Congress to fully understand all the implications of FDA regulation. It is likely that during the coming year, Congress will pass legislation bringing tobacco products under the regulatory authority of the FDA. Allan Brandt writes that it behooves public health advocates and Congress to fully understand all the implications of FDA regulation. tag:odeo.com,2008-07-30,23130886 Wed, 30 Jul 2008 08:00:00 -0700 no NEJM Interviews with PDF http://www.odeo.com/episodes/23197809-Perspective-PDF-The-President-s-Emergency-Plan-for-AIDS-Relief-Is-the-Emergency-Over On July 16, the Senate approved legislation that would increase the funding for the President’s Emergency Plan for AIDS Relief (PEPFAR) to $48 billion for the next 5 years. Drs. Wafaa El-Sadr and David Hoos examine PEPFAR’s achievements, limitations, and lessons for the future. On July 16, the Senate approved legislation that would increase the funding for the President’s Emergency Plan for AIDS Relief (PEPFAR) to $48 billion for the next 5 years. Drs. Wafaa El-Sadr and David Hoos examine PEPFAR’s achievements, limitations, and lessons for the future. On July 16, the Senate approved legislation that would increase the funding for the President’s Emergency Plan for AIDS Relief (PEPFAR) to $48 billion for the next 5 years. Drs. Wafaa El-Sadr and David Hoos examine PEPFAR’s achievements, limitations, and lessons for the future. tag:odeo.com,2008-07-30,23197809 Wed, 30 Jul 2008 08:00:00 -0700 no NEJM Interviews with PDF http://www.odeo.com/episodes/23197811-Perspective-PDF-FDA-Regulation-of-Tobacco-Pitfalls-and-Possibilities It is likely that during the coming year, Congress will pass legislation bringing tobacco products under the regulatory authority of the FDA. Allan Brandt writes that it behooves public health advocates and Congress to fully understand all the implications of FDA regulation. It is likely that during the coming year, Congress will pass legislation bringing tobacco products under the regulatory authority of the FDA. Allan Brandt writes that it behooves public health advocates and Congress to fully understand all the implications of FDA regulation. It is likely that during the coming year, Congress will pass legislation bringing tobacco products under the regulatory authority of the FDA. Allan Brandt writes that it behooves public health advocates and Congress to fully understand all the implications of FDA regulation. tag:odeo.com,2008-07-30,23197811 Wed, 30 Jul 2008 08:00:00 -0700 no NEJM Interviews with PDF http://www.odeo.com/episodes/23026780-NEJM-Interview-Jon-Kingsdale-on-the-Massachusetts-mandate-for-universal-health-insurance-coverage-and-its-lessons-for-the-rest-of-the-United-States Jon Kingsdale is the executive director of the Commonwealth Health Insurance Connector Authority, Boston. Rachel Gotbaum is an independent producer based in Boston. Supplement to: Steinbrook R. Health Care Reform in Massachusetts -- Expanding Coverage, Escalating Costs. N Engl J Med 2008;358:2757-60. Jon Kingsdale is the executive director of the Commonwealth Health Insurance Connector Authority, Boston. Rachel Gotbaum is an independent producer based in Boston. Supplement to: Steinbrook R. Health Care Reform in Massachusetts -- Expanding Coverage, Escalating Costs. N Engl J Med 2008;358:2757-60. Jon Kingsdale is the executive director of the Commonwealth Health Insurance Connector Authority, Boston. Rachel Gotbaum is an independent producer based in Boston. Supplement to: Steinbrook R. Health Care Reform in Massachusetts -- Expanding Coverage, Escalating Costs. N Engl J Med 2008;358:2757-60. tag:odeo.com,2008-06-25,23026780 Wed, 25 Jun 2008 08:01:00 -0700 no NEJM Interviews with PDF http://www.odeo.com/episodes/23026781-Perspective-PDF-Health-Care-Reform-in-Massachusetts-Expanding-Coverage-Escalating-Costs After 2 years, the good news is that the health care reforms in Massachusetts have ramped up rapidly, the number of people without health insurance has been substantially reduced, and overall public and political support remains broad. Dr. Robert Steinbrook writes that not all the news is good, however. After 2 years, the good news is that the health care reforms in Massachusetts have ramped up rapidly, the number of people without health insurance has been substantially reduced, and overall public and political support remains broad. Dr. Robert Steinbrook writes that not all the news is good, however. After 2 years, the good news is that the health care reforms in Massachusetts have ramped up rapidly, the number of people without health insurance has been substantially reduced, and overall public and political support remains broad. Dr. Robert Steinbrook writes that not all the news is good, however. tag:odeo.com,2008-06-25,23026781 Wed, 25 Jun 2008 08:00:00 -0700 no NEJM Interviews with PDF http://www.odeo.com/episodes/23004892-NEJM-Interview-Francis-Collins-discusses-the-provisions-of-the-Genetic-Information-Nondiscrimination-Act-and-its-likely-effects-on-patient-care-and-clinical-research Francis Collins is director of the National Human Genome Research Institute at the National Institutes of Health. Rachel Gotbaum is an independent producer based in Boston. Supplement to: Hudson KL, Holohan MK, and Collins FS. Keeping Pace with the Times -- The Genetic Information Nondiscrimination Act of 2008. N Engl J Med 2008;358:2661-3. Francis Collins is director of the National Human Genome Research Institute at the National Institutes of Health. Rachel Gotbaum is an independent producer based in Boston. Supplement to: Hudson KL, Holohan MK, and Collins FS. Keeping Pace with the Times -- The Genetic Information Nondiscrimination Act of 2008. N Engl J Med 2008;358:2661-3. Francis Collins is director of the National Human Genome Research Institute at the National Institutes of Health. Rachel Gotbaum is an independent producer based in Boston. Supplement to: Hudson KL, Holohan MK, and Collins FS. Keeping Pace with the Times -- The Genetic Information Nondiscrimination Act of 2008. N Engl J Med 2008;358:2661-3. tag:odeo.com,2008-06-18,23004892 Wed, 18 Jun 2008 08:01:00 -0700 no NEJM Interviews with PDF http://www.odeo.com/episodes/23004893-Perspective-PDF-Keeping-Pace-with-the-Times-The-Genetic-Information-Nondiscrimination-Act-of-2008 On May 21, President George Bush signed the Genetic Information Nondiscrimination Act (GINA). Kathy Hudson, M.K. Holohan, and Dr. Francis Collins write that at last, the United States has a federal law that protects consumers from discrimination by health insurers and employers on the basis of genetic information. On May 21, President George Bush signed the Genetic Information Nondiscrimination Act (GINA). Kathy Hudson, M.K. Holohan, and Dr. Francis Collins write that at last, the United States has a federal law that protects consumers from discrimination by health insurers and employers on the basis of genetic information. On May 21, President George Bush signed the Genetic Information Nondiscrimination Act (GINA). Kathy Hudson, M.K. Holohan, and Dr. Francis Collins write that at last, the United States has a federal law that protects consumers from discrimination by health insurers and employers on the basis of genetic information. tag:odeo.com,2008-06-18,23004893 Wed, 18 Jun 2008 08:00:00 -0700 no NEJM Interviews with PDF http://www.odeo.com/episodes/22583402-NEJM-Interview-Janet-Woodcock-on-the-contaminated-heparin-from-China-and-the-role-of-the-FDA Janet Woodcock is director of the Center for Drug Evaluation and Research at the Food and Drug Administration. Rachel Gotbaum is an independent producer based in Boston. Supplement to: Avorn J. Coagulation and Adulteration -- Building on Science and Policy Lessons from 1905. N Engl J Med 2008;358:2429-31. Janet Woodcock is director of the Center for Drug Evaluation and Research at the Food and Drug Administration. Rachel Gotbaum is an independent producer based in Boston. Supplement to: Avorn J. Coagulation and Adulteration -- Building on Science and Policy Lessons from 1905. N Engl J Med 2008;358:2429-31. Janet Woodcock is director of the Center for Drug Evaluation and Research at the Food and Drug Administration. Rachel Gotbaum is an independent producer based in Boston. Supplement to: Avorn J. Coagulation and Adulteration -- Building on Science and Policy Lessons from 1905. N Engl J Med 2008;358:2429-31. tag:odeo.com,2008-06-04,22583402 Wed, 04 Jun 2008 08:01:00 -0700 no NEJM Interviews with PDF http://www.odeo.com/episodes/22583403-Perspective-PDF-Coagulation-and-Adulteration-Building-on-Science-and-Policy-Lessons-from-1905 It's always instructive and often painful to contrast the impressive development of medical science with the more fitful evolution of health policy. The former marches forward more or less systematically; well-developed rules of evidence determine what works, and practical methods build on established facts and test new paradigms. Data and concepts proven true are rarely discarded or forgotten. Not so with health policy. It's always instructive and often painful to contrast the impressive development of medical science with the more fitful evolution of health policy. The former marches forward more or less systematically; well-developed rules of evidence determine what works, and practical methods build on established facts and test new paradigms. Data and concepts proven true are rarely discarded or forgotten. Not so with health policy. It's always instructive and often painful to contrast the impressive development of medical science with the more fitful evolution of health policy. The former marches forward more or less systematically; well-developed rules of evidence determine what works, and practical methods build on established facts and test new paradigms. Data and concepts proven true are rarely discarded or forgotten. Not so with health policy. tag:odeo.com,2008-06-04,22583403 Wed, 04 Jun 2008 08:00:00 -0700 no NEJM Interviews with PDF http://www.odeo.com/episodes/25399265-NEJM-Interview-Stuart-Schweitzer-on-challenges-faced-by-the-FDA Stuart Schweitzer is a professor in the Department of Health Services at the UCLA School of Public Health, Los Angeles. Rachel Gotbaum is an independent producer based in Boston. Supplement to: Schweitzer SO. Trying Times at the FDA -- The Challenge of Ensuring the Safety of Imported Pharmaceuticals. N Engl J Med 2008;358:1773-7. Stuart Schweitzer is a professor in the Department of Health Services at the UCLA School of Public Health, Los Angeles. Rachel Gotbaum is an independent producer based in Boston. Supplement to: Schweitzer SO. Trying Times at the FDA -- The Challenge of Ensuring the Safety of Imported Pharmaceuticals. N Engl J Med 2008;358:1773-7. Stuart Schweitzer is a professor in the Department of Health Services at the UCLA School of Public Health, Los Angeles. Rachel Gotbaum is an independent producer based in Boston. Supplement to: Schweitzer SO. Trying Times at the FDA -- The Challenge of Ensuring the Safety of Imported Pharmaceuticals. N Engl J Med 2008;358:1773-7. tag:odeo.com,2008-04-23,25399265 Wed, 23 Apr 2008 08:01:00 -0700 no NEJM Interviews with PDF http://www.odeo.com/episodes/25399266-Perspective-PDF-Trying-Times-at-the-FDA-The-Challenge-of-Ensuring-the-Safety-of-Imported-Pharmaceuticals Stuart Schweitzer discusses challenges and recent crises at the FDA and the scope of the agency's responsibilities. Stuart Schweitzer discusses challenges and recent crises at the FDA and the scope of the agency's responsibilities. Stuart Schweitzer discusses challenges and recent crises at the FDA and the scope of the agency's responsibilities. tag:odeo.com,2008-04-23,25399266 Wed, 23 Apr 2008 08:00:00 -0700 no NEJM Interviews with PDF http://www.odeo.com/episodes/22471123-NEJM-Interview-Stuart-Schweitzer-on-challenges-faced-by-the-FDA Stuart Schweitzer is a professor in the Department of Health Services at the UCLA School of Public Health, Los Angeles. Rachel Gotbaum is an independent producer based in Boston. Supplement to: Schweitzer SO. Trying Times at the FDA -- The Challenge of Ensuring the Safety of Imported Pharmaceuticals. N Engl J Med 2008;358:1773-7. Stuart Schweitzer is a professor in the Department of Health Services at the UCLA School of Public Health, Los Angeles. Rachel Gotbaum is an independent producer based in Boston. Supplement to: Schweitzer SO. Trying Times at the FDA -- The Challenge of Ensuring the Safety of Imported Pharmaceuticals. N Engl J Med 2008;358:1773-7. Stuart Schweitzer is a professor in the Department of Health Services at the UCLA School of Public Health, Los Angeles. Rachel Gotbaum is an independent producer based in Boston. Supplement to: Schweitzer SO. Trying Times at the FDA -- The Challenge of Ensuring the Safety of Imported Pharmaceuticals. N Engl J Med 2008;358:1773-7. tag:odeo.com,2008-04-23,22471123 Wed, 23 Apr 2008 07:01:00 -0700 no NEJM Interviews with PDF http://www.odeo.com/episodes/22471124-Perspective-PDF-Trying-Times-at-the-FDA-The-Challenge-of-Ensuring-the-Safety-of-Imported-Pharmaceuticals Stuart Schweitzer discusses challenges and recent crises at the FDA and the scope of the agency's responsibilities. Stuart Schweitzer discusses challenges and recent crises at the FDA and the scope of the agency's responsibilities. Stuart Schweitzer discusses challenges and recent crises at the FDA and the scope of the agency's responsibilities. tag:odeo.com,2008-04-23,22471124 Wed, 23 Apr 2008 07:00:00 -0700 no NEJM Interviews with PDF http://www.odeo.com/episodes/25399267-NEJM-Interview-Sherry-Glied-on-the-risks-and-benefits-of-individual-health-insurance-mandates Sherry Glied is a professor and chair of the Department of Health Policy and Management, Mailman School of Public Health, Columbia University, New York. Rachel Gotbaum is an independent producer based in Boston. Supplement to: Glied SA. Universal Coverage One Head at a Time -- The Risks and Benefits of Individual Health Insurance Mandates. N Engl J Med 2008;358:1540-2. Sherry Glied is a professor and chair of the Department of Health Policy and Management, Mailman School of Public Health, Columbia University, New York. Rachel Gotbaum is an independent producer based in Boston. Supplement to: Glied SA. Universal Coverage One Head at a Time -- The Risks and Benefits of Individual Health Insurance Mandates. N Engl J Med 2008;358:1540-2. Sherry Glied is a professor and chair of the Department of Health Policy and Management, Mailman School of Public Health, Columbia University, New York. Rachel Gotbaum is an independent producer based in Boston. Supplement to: Glied SA. Universal Coverage One Head at a Time -- The Risks and Benefits of Individual Health Insurance Mandates. N Engl J Med 2008;358:1540-2. tag:odeo.com,2008-04-09,25399267 Wed, 09 Apr 2008 08:01:00 -0700 no NEJM Interviews with PDF http://www.odeo.com/episodes/25399271-Perspective-PDF-Universal-Coverage-One-Head-at-a-Time-The-Risks-and-Benefits-of-Individual-Health-Insurance-Mandates The health insurance reform enacted in Massachusetts in 2006 and the proposals of the leading Democratic presidential candidates seek to achieve universal health insurance coverage while relying primarily on private insurance. Achieving universality is a challenge in any system that assigns insurance coverage, whether private or public... The health insurance reform enacted in Massachusetts in 2006 and the proposals of the leading Democratic presidential candidates seek to achieve universal health insurance coverage while relying primarily on private insurance. Achieving universality is a challenge in any system that assigns insurance coverage, whether private or public... The health insurance reform enacted in Massachusetts in 2006 and the proposals of the leading Democratic presidential candidates seek to achieve universal health insurance coverage while relying primarily on private insurance. Achieving universality is a challenge in any system that assigns insurance coverage, whether private or public... tag:odeo.com,2008-04-09,25399271 Wed, 09 Apr 2008 08:00:00 -0700 no NEJM Interviews with PDF http://www.odeo.com/episodes/22398901-NEJM-Interview-Sherry-Glied-on-the-risks-and-benefits-of-individual-health-insurance-mandates Sherry Glied is a professor and chair of the Department of Health Policy and Management, Mailman School of Public Health, Columbia University, New York. Rachel Gotbaum is an independent producer based in Boston. Supplement to: Glied SA. Universal Coverage One Head at a Time -- The Risks and Benefits of Individual Health Insurance Mandates. N Engl J Med 2008;358:1540-2. Sherry Glied is a professor and chair of the Department of Health Policy and Management, Mailman School of Public Health, Columbia University, New York. Rachel Gotbaum is an independent producer based in Boston. Supplement to: Glied SA. Universal Coverage One Head at a Time -- The Risks and Benefits of Individual Health Insurance Mandates. N Engl J Med 2008;358:1540-2. Sherry Glied is a professor and chair of the Department of Health Policy and Management, Mailman School of Public Health, Columbia University, New York. Rachel Gotbaum is an independent producer based in Boston. Supplement to: Glied SA. Universal Coverage One Head at a Time -- The Risks and Benefits of Individual Health Insurance Mandates. N Engl J Med 2008;358:1540-2. tag:odeo.com,2008-04-09,22398901 Wed, 09 Apr 2008 07:01:00 -0700 no NEJM Interviews with PDF http://www.odeo.com/episodes/22398902-Perspective-PDF-Universal-Coverage-One-Head-at-a-Time-The-Risks-and-Benefits-of-Individual-Health-Insurance-Mandates The health insurance reform enacted in Massachusetts in 2006 and the proposals of the leading Democratic presidential candidates seek to achieve universal health insurance coverage while relying primarily on private insurance. Achieving universality is a challenge in any system that assigns insurance coverage, whether private or public... The health insurance reform enacted in Massachusetts in 2006 and the proposals of the leading Democratic presidential candidates seek to achieve universal health insurance coverage while relying primarily on private insurance. Achieving universality is a challenge in any system that assigns insurance coverage, whether private or public... The health insurance reform enacted in Massachusetts in 2006 and the proposals of the leading Democratic presidential candidates seek to achieve universal health insurance coverage while relying primarily on private insurance. Achieving universality is a challenge in any system that assigns insurance coverage, whether private or public... tag:odeo.com,2008-04-09,22398902 Wed, 09 Apr 2008 07:00:00 -0700 no NEJM Interviews with PDF http://www.odeo.com/episodes/22187453-NEJM-Interview-David-Hemenway-on-gun-violence-in-the-United-States-and-the-likely-effects-of-the-Supreme-Court-case-D-C-v-Heller David Hemenway is a professor of health policy at the Harvard School of Public Health, Boston. Rachel Gotbaum is an independent producer based in Boston. Supplement to: Curfman GD, Morrissey S, and Drazen JM. Handgun Violence, Public Health, and the Law. N Engl J Med 2008;358. DOI: 10.1056/NEJMe0802118. David Hemenway is a professor of health policy at the Harvard School of Public Health, Boston. Rachel Gotbaum is an independent producer based in Boston. Supplement to: Curfman GD, Morrissey S, and Drazen JM. Handgun Violence, Public Health, and the Law. N Engl J Med 2008;358. DOI: 10.1056/NEJMe0802118. David Hemenway is a professor of health policy at the Harvard School of Public Health, Boston. Rachel Gotbaum is an independent producer based in Boston. Supplement to: Curfman GD, Morrissey S, and Drazen JM. Handgun Violence, Public Health, and the Law. N Engl J Med 2008;358. DOI: 10.1056/NEJMe0802118. tag:odeo.com,2008-03-19,22187453 Wed, 19 Mar 2008 07:01:00 -0700 no NEJM Interviews with PDF http://www.odeo.com/episodes/22187454-Perspective-PDF-Handgun-Violence-Public-Health-and-the-Law On March 18, the Supreme Court heard oral arguments in the case of District of Columbia v. Heller, a case challenging handgun control statutes adopted in 1976. On March 18, the Supreme Court heard oral arguments in the case of District of Columbia v. Heller, a case challenging handgun control statutes adopted in 1976. On March 18, the Supreme Court heard oral arguments in the case of District of Columbia v. Heller, a case challenging handgun control statutes adopted in 1976. tag:odeo.com,2008-03-19,22187454 Wed, 19 Mar 2008 07:00:00 -0700 no NEJM Interviews with PDF http://www.odeo.com/episodes/22119729-NEJM-Interview-Mohamed-Ali-on-violence-related-mortality-among-Iraqi-civilians Mohamed Ali is a statistician in the Department of Measurement and Health Information Systems at the World Health Organization in Geneva, Switzerland. Rachel Gotbaum is an independent producer based in Boston. Supplement to: Brownstein CA and Brownstein JS. Estimating Excess Mortality in Post-Invasion Iraq. N Engl J Med 2008;358:445-7. Mohamed Ali is a statistician in the Department of Measurement and Health Information Systems at the World Health Organization in Geneva, Switzerland. Rachel Gotbaum is an independent producer based in Boston. Supplement to: Brownstein CA and Brownstein JS. Estimating Excess Mortality in Post-Invasion Iraq. N Engl J Med 2008;358:445-7. Mohamed Ali is a statistician in the Department of Measurement and Health Information Systems at the World Health Organization in Geneva, Switzerland. Rachel Gotbaum is an independent producer based in Boston. Supplement to: Brownstein CA and Brownstein JS. Estimating Excess Mortality in Post-Invasion Iraq. N Engl J Med 2008;358:445-7. tag:odeo.com,2008-01-30,22119729 Wed, 30 Jan 2008 07:01:00 -0800 no NEJM Interviews with PDF http://www.odeo.com/episodes/22119730-Perspective-PDF-Estimating-Excess-Mortality-in-Post-Invasion-Iraq There is no set formula for accurately tallying deaths from humanitarian crises. When a population becomes destabilized, estimation of mortality is likely to be severely challenged. There is no set formula for accurately tallying deaths from humanitarian crises. When a population becomes destabilized, estimation of mortality is likely to be severely challenged. There is no set formula for accurately tallying deaths from humanitarian crises. When a population becomes destabilized, estimation of mortality is likely to be severely challenged. tag:odeo.com,2008-01-30,22119730 Wed, 30 Jan 2008 07:00:00 -0800 no NEJM Interviews with PDF http://www.odeo.com/episodes/22104104-NEJM-Interview-Atul-Gawande-Deborah-Denno-Robert-Truog-and-David-Waisel-on-lethal-injection On January 7, the Supreme Court heard oral arguments about lethal injection in Baze v. Rees. The Journal presents a video roundtable discussion, moderated by Dr. Atul Gawande, about lethal injection, the three-drug protocol used, and the involvement of health care professionals in capital punishment. On January 7, the Supreme Court heard oral arguments about lethal injection in Baze v. Rees. The Journal presents a video roundtable discussion, moderated by Dr. Atul Gawande, about lethal injection, the three-drug protocol used, and the involvement of health care professionals in capital punishment. On January 7, the Supreme Court heard oral arguments about lethal injection in Baze v. Rees. The Journal presents a video roundtable discussion, moderated by Dr. Atul Gawande, about lethal injection, the three-drug protocol used, and the involvement of health care professionals in capital punishment. tag:odeo.com,2008-01-23,22104104 Wed, 23 Jan 2008 08:01:00 -0800 no NEJM Interviews with PDF http://www.odeo.com/episodes/22079298-NEJM-Interview-Peggy-Porter-on-the-increased-rate-of-breast-cancer-in-lower-income-countries Peggy Porter is a cancer biology researcher at the Fred Hutchinson Cancer Research Center and a professor of pathology at the University of Washington School of Medicine, Seattle. Rachel Gotbaum, the interviewer, is an independent producer based in Boston. Supplement to: Porter P. "Westernizing" Women's Risks? Breast Cancer in Lower-Income Countries. N Engl J Med 2008;358:213-6. Peggy Porter is a cancer biology researcher at the Fred Hutchinson Cancer Research Center and a professor of pathology at the University of Washington School of Medicine, Seattle. Rachel Gotbaum, the interviewer, is an independent producer based in Boston. Supplement to: Porter P. "Westernizing" Women's Risks? Breast Cancer in Lower-Income Countries. N Engl J Med 2008;358:213-6. Peggy Porter is a cancer biology researcher at the Fred Hutchinson Cancer Research Center and a professor of pathology at the University of Washington School of Medicine, Seattle. Rachel Gotbaum, the interviewer, is an independent producer based in Boston. Supplement to: Porter P. "Westernizing" Women's Risks? Breast Cancer in Lower-Income Countries. N Engl J Med 2008;358:213-6. tag:odeo.com,2008-01-16,22079298 Wed, 16 Jan 2008 08:01:00 -0800 no NEJM Interviews with PDF http://www.odeo.com/episodes/22079299-Perspective-PDF-Westernizing-Women-s-Risks-Breast-Cancer-in-Lower-Income-Countries Recent media reports have highlighted the increasing incidence of breast cancer in low- and middle-income countries. Although the disease continues to be most prominent in affluent countries, the risks of both breast cancer and death due to breast cancer are clearly increasing worldwide. Recent media reports have highlighted the increasing incidence of breast cancer in low- and middle-income countries. Although the disease continues to be most prominent in affluent countries, the risks of both breast cancer and death due to breast cancer are clearly increasing worldwide. Recent media reports have highlighted the increasing incidence of breast cancer in low- and middle-income countries. Although the disease continues to be most prominent in affluent countries, the risks of both breast cancer and death due to breast cancer are clearly increasing worldwide. tag:odeo.com,2008-01-16,22079299 Wed, 16 Jan 2008 08:00:00 -0800 no NEJM Interviews with PDF http://www.odeo.com/episodes/22017655-NEJM-Interview-Muin-Khoury-on-personal-genomics-services-being-offered-directly-to-consumers Dr. Muin Khoury is the director of the National Office of Public Health Genomics at the Centers for Disease Control and Prevention, Atlanta. Rachel Gotbaum, the interviewer, is an independent producer based in Boston. Supplement to: Hunter DJ, Khoury MJ, and Drazen JM. Letting the Genome out of the Bottle - Will We Get Our Wish? N Engl J Med 2008;358(2):105-7. Dr. Muin Khoury is the director of the National Office of Public Health Genomics at the Centers for Disease Control and Prevention, Atlanta. Rachel Gotbaum, the interviewer, is an independent producer based in Boston. Supplement to: Hunter DJ, Khoury MJ, and Drazen JM. Letting the Genome out of the Bottle - Will We Get Our Wish? N Engl J Med 2008;358(2):105-7. Dr. Muin Khoury is the director of the National Office of Public Health Genomics at the Centers for Disease Control and Prevention, Atlanta. Rachel Gotbaum, the interviewer, is an independent producer based in Boston. Supplement to: Hunter DJ, Khoury MJ, and Drazen JM. Letting the Genome out of the Bottle - Will We Get Our Wish? N Engl J Med 2008;358(2):105-7. tag:odeo.com,2008-01-09,22017655 Wed, 09 Jan 2008 08:01:00 -0800 no NEJM Interviews with PDF http://www.odeo.com/episodes/22079031-Perspective-PDF-Letting-the-Genome-out-of-the-Bottle-Will-We-Get-Our-Wish A patient shows up in your office with an analysis of his whole genome at multiple single-nucleotide polymorphisms (SNPs). What should you do? David Hunter, Dr. Muin Khoury, and Dr. Jeffrey Drazen discuss the analytic and clinical validity of personal genomics testing. A patient shows up in your office with an analysis of his whole genome at multiple single-nucleotide polymorphisms (SNPs). What should you do? David Hunter, Dr. Muin Khoury, and Dr. Jeffrey Drazen discuss the analytic and clinical validity of personal genomics testing. A patient shows up in your office with an analysis of his whole genome at multiple single-nucleotide polymorphisms (SNPs). What should you do? David Hunter, Dr. Muin Khoury, and Dr. Jeffrey Drazen discuss the analytic and clinical validity of personal genomics testing. tag:odeo.com,2008-01-09,22079031 Wed, 09 Jan 2008 08:00:00 -0800 no NEJM Interviews with PDF http://www.odeo.com/episodes/22017662-NEJM-Interview-Thomas-Lee-discusses-the-goals-stumbling-blocks-and-applications-of-quality-and-efficiency-measurement Dr. Thomas Lee is network president for Partners Healthcare in Boston. Rachel Gotbaum, the interviewer, is an independent producer based in Boston. Supplement to: Milstein A and Lee TH. Comparing Physicians on Efficiency. N Engl J Med 2007;357(26):2649-52. Dr. Thomas Lee is network president for Partners Healthcare in Boston. Rachel Gotbaum, the interviewer, is an independent producer based in Boston. Supplement to: Milstein A and Lee TH. Comparing Physicians on Efficiency. N Engl J Med 2007;357(26):2649-52. Dr. Thomas Lee is network president for Partners Healthcare in Boston. Rachel Gotbaum, the interviewer, is an independent producer based in Boston. Supplement to: Milstein A and Lee TH. Comparing Physicians on Efficiency. N Engl J Med 2007;357(26):2649-52. tag:odeo.com,2007-12-26,22017662 Wed, 26 Dec 2007 08:01:00 -0800 no NEJM Interviews with PDF http://www.odeo.com/episodes/22079032-Perspective-PDF-Comparing-Physicians-on-Efficiency What are the controversies surrounding the use of physician-efficiency assessments by consumers and purchasers? Can reasonable compromises be struck between physicians and these two kinds of customers? What are the controversies surrounding the use of physician-efficiency assessments by consumers and purchasers? Can reasonable compromises be struck between physicians and these two kinds of customers? What are the controversies surrounding the use of physician-efficiency assessments by consumers and purchasers? Can reasonable compromises be struck between physicians and these two kinds of customers? tag:odeo.com,2007-12-26,22079032 Wed, 26 Dec 2007 08:00:00 -0800 no NEJM Interviews with PDF http://www.odeo.com/episodes/22017675-NEJM-Interview-Gretchen-Berland-and-J-Galen-Buckwalter-on-video-recording-and-revelations-about-interactions-between-physicians-and-patients-with-disabilities Gretchen Berland is an assistant professor of medicine at Yale University School of Medicine, New Haven, CT. Galen Buckwalter is vice president of research and development at eHarmony.com. Rachel Gotbaum, the interviewer, is an independent producer based in Boston. Supplement to: Berland G. The View from the Other Side -- Patients, Doctors, and the Power of a Camera. N Engl J Med 2007;357(25):2533-6. Gretchen Berland is an assistant professor of medicine at Yale University School of Medicine, New Haven, CT. Galen Buckwalter is vice president of research and development at eHarmony.com. Rachel Gotbaum, the interviewer, is an independent producer based in Boston. Supplement to: Berland G. The View from the Other Side -- Patients, Doctors, and the Power of a Camera. N Engl J Med 2007;357(25):2533-6. Gretchen Berland is an assistant professor of medicine at Yale University School of Medicine, New Haven, CT. Galen Buckwalter is vice president of research and development at eHarmony.com. Rachel Gotbaum, the interviewer, is an independent producer based in Boston. Supplement to: Berland G. The View from the Other Side -- Patients, Doctors, and the Power of a Camera. N Engl J Med 2007;357(25):2533-6. tag:odeo.com,2007-12-19,22017675 Wed, 19 Dec 2007 08:01:00 -0800 no NEJM Interviews with PDF http://www.odeo.com/episodes/22079033-Perspective-PDF-The-View-from-the-Other-Side-Patients-Doctors-and-the-Power-of-a-Camera Dr. Gretchen Berland gave video cameras to volunteers in wheelchairs in order to understand the experience of being disabled. She writes that the project taught her to see the world in ways she had never imagined. Dr. Gretchen Berland gave video cameras to volunteers in wheelchairs in order to understand the experience of being disabled. She writes that the project taught her to see the world in ways she had never imagined. Dr. Gretchen Berland gave video cameras to volunteers in wheelchairs in order to understand the experience of being disabled. She writes that the project taught her to see the world in ways she had never imagined. tag:odeo.com,2007-12-19,22079033 Wed, 19 Dec 2007 08:00:00 -0800 no NEJM Interviews with PDF http://www.odeo.com/episodes/22017684-NEJM-Interview-Susan-Dymecki-on-gene-modification-in-mice-and-the-2007-Nobel-Prize-in-Medicine-or-Physiology Susan Dymecki is associate professor of genetics at Harvard Medical School, Boston. Rachel Gotbaum, the interviewer, is an independent producer based in Boston. Supplement to: Manis JP. Knock Out, Knock In, Knock Down -- Genetically Manipulated Mice and the Nobel Prize. N Engl J Med 2007;357(24):2426-9. Susan Dymecki is associate professor of genetics at Harvard Medical School, Boston. Rachel Gotbaum, the interviewer, is an independent producer based in Boston. Supplement to: Manis JP. Knock Out, Knock In, Knock Down -- Genetically Manipulated Mice and the Nobel Prize. N Engl J Med 2007;357(24):2426-9. Susan Dymecki is associate professor of genetics at Harvard Medical School, Boston. Rachel Gotbaum, the interviewer, is an independent producer based in Boston. Supplement to: Manis JP. Knock Out, Knock In, Knock Down -- Genetically Manipulated Mice and the Nobel Prize. N Engl J Med 2007;357(24):2426-9. tag:odeo.com,2007-12-12,22017684 Wed, 12 Dec 2007 08:01:00 -0800 no NEJM Interviews with PDF http://www.odeo.com/episodes/22079034-Perspective-PDF-Knock-Out-Knock-In-Knock-Down-Genetically-Manipulated-Mice-and-the-Nobel-Prize In Stockholm this fall, the Nobel Prize in Medicine or Physiology was awarded to Martin Evans, Oliver Smithies, and Mario Capecchi for their discoveries of "principles for introducing specific gene modifications in mice by the use of embryonic stem cells." In Stockholm this fall, the Nobel Prize in Medicine or Physiology was awarded to Martin Evans, Oliver Smithies, and Mario Capecchi for their discoveries of "principles for introducing specific gene modifications in mice by the use of embryonic stem cells." In Stockholm this fall, the Nobel Prize in Medicine or Physiology was awarded to Martin Evans, Oliver Smithies, and Mario Capecchi for their discoveries of "principles for introducing specific gene modifications in mice by the use of embryonic stem cells." tag:odeo.com,2007-12-12,22079034 Wed, 12 Dec 2007 08:00:00 -0800 no NEJM Interviews with PDF http://www.odeo.com/episodes/22017692-NEJM-Interview-David-Ludwig-on-the-impact-of-the-childhood-obesity-epidemic David Ludwig is director of the Optimal Weight for Life Program in the Division of Endocrinology, Children's Hospital Boston, and an associate professor of pediatrics at Harvard Medical School - both in Boston. Rachel Gotbaum, the interviewer, is an independent producer based in Boston. Supplement to: Ludwig DS. Childhood Obesity -- The Shape of Things to Come. N Engl J Med 2007;357(23):2325-7. David Ludwig is director of the Optimal Weight for Life Program in the Division of Endocrinology, Children's Hospital Boston, and an associate professor of pediatrics at Harvard Medical School - both in Boston. Rachel Gotbaum, the interviewer, is an independent producer based in Boston. Supplement to: Ludwig DS. Childhood Obesity -- The Shape of Things to Come. N Engl J Med 2007;357(23):2325-7. David Ludwig is director of the Optimal Weight for Life Program in the Division of Endocrinology, Children's Hospital Boston, and an associate professor of pediatrics at Harvard Medical School - both in Boston. Rachel Gotbaum, the interviewer, is an independent producer based in Boston. Supplement to: Ludwig DS. Childhood Obesity -- The Shape of Things to Come. N Engl J Med 2007;357(23):2325-7. tag:odeo.com,2007-12-05,22017692 Wed, 05 Dec 2007 08:01:00 -0800 no NEJM Interviews with PDF http://www.odeo.com/episodes/22079035-Perspective-PDF-Childhood-Obesity-The-Shape-of-Things-to-Come Dr. David Ludwig writes that if we don't take steps to reverse the course of the obesity epidemic, the children of each successive generation seem destined to be fatter and sicker than their parents. Ludwig discusses four overlapping phases of the epidemic. Dr. David Ludwig writes that if we don't take steps to reverse the course of the obesity epidemic, the children of each successive generation seem destined to be fatter and sicker than their parents. Ludwig discusses four overlapping phases of the epidemic. Dr. David Ludwig writes that if we don't take steps to reverse the course of the obesity epidemic, the children of each successive generation seem destined to be fatter and sicker than their parents. Ludwig discusses four overlapping phases of the epidemic. tag:odeo.com,2007-12-05,22079035 Wed, 05 Dec 2007 08:00:00 -0800 no NEJM Interviews with PDF http://www.odeo.com/episodes/22017707-NEJM-Interview-Thomas-Monath-on-dengue-and-yellow-fever-and-the-challenges-faced-in-the-development-and-use-of-vaccines-against-them Thomas Monath, an adjunct professor at the Harvard School of Public Health, Boston, spent many years studying, and developing vaccines against, dengue and yellow fever. Rachel Gotbaum, the interviewer, is an independent producer based in Boston. Supplement to: Monath TP. Dengue and Yellow Fever -- Challenges for the Development and Use of Vaccines. N Engl J Med 2007;357(22):2222-5. Thomas Monath, an adjunct professor at the Harvard School of Public Health, Boston, spent many years studying, and developing vaccines against, dengue and yellow fever. Rachel Gotbaum, the interviewer, is an independent producer based in Boston. Supplement to: Monath TP. Dengue and Yellow Fever -- Challenges for the Development and Use of Vaccines. N Engl J Med 2007;357(22):2222-5. Thomas Monath, an adjunct professor at the Harvard School of Public Health, Boston, spent many years studying, and developing vaccines against, dengue and yellow fever. Rachel Gotbaum, the interviewer, is an independent producer based in Boston. Supplement to: Monath TP. Dengue and Yellow Fever -- Challenges for the Development and Use of Vaccines. N Engl J Med 2007;357(22):2222-5. tag:odeo.com,2007-11-28,22017707 Wed, 28 Nov 2007 08:01:00 -0800 no NEJM Interviews with PDF http://www.odeo.com/episodes/22079036-Perspective-PDF-Dengue-and-Yellow-Fever-Challenges-for-the-Development-and-Use-of-Vaccines Thomas Monath discusses the global threat represented by dengue and yellow fever and the challenges faced in the development and use of vaccines against them. Thomas Monath discusses the global threat represented by dengue and yellow fever and the challenges faced in the development and use of vaccines against them. Thomas Monath discusses the global threat represented by dengue and yellow fever and the challenges faced in the development and use of vaccines against them. tag:odeo.com,2007-11-28,22079036 Wed, 28 Nov 2007 08:00:00 -0800 no NEJM Interviews with PDF http://www.odeo.com/episodes/22017766-NEJM-Interview-Jonathan-Oberlander-on-health-care-reform-and-the-presidential-campaign Jonathan Oberlander is an associate professor of social medicine and of health policy and administration at the University of North Carolina, Chapel Hill. Rachel Gotbaum, the interviewer, is an independent producer based in Boston. Supplement to: Oberlander J. Presidential Politics and the Resurgence of Health Care Reform. N Engl J Med 2007;357(21):2101-4. Jonathan Oberlander is an associate professor of social medicine and of health policy and administration at the University of North Carolina, Chapel Hill. Rachel Gotbaum, the interviewer, is an independent producer based in Boston. Supplement to: Oberlander J. Presidential Politics and the Resurgence of Health Care Reform. N Engl J Med 2007;357(21):2101-4. Jonathan Oberlander is an associate professor of social medicine and of health policy and administration at the University of North Carolina, Chapel Hill. Rachel Gotbaum, the interviewer, is an independent producer based in Boston. Supplement to: Oberlander J. Presidential Politics and the Resurgence of Health Care Reform. N Engl J Med 2007;357(21):2101-4. tag:odeo.com,2007-11-21,22017766 Wed, 21 Nov 2007 08:01:00 -0800 no NEJM Interviews with PDF http://www.odeo.com/episodes/22079037-Perspective-PDF-Presidential-Politics-and-the-Resurgence-of-Health-Care-Reform Democratic and Republican voters have contrasting views on health care reform, so not surprisingly, the issue is playing out very differently in the parties' presidential primaries. Democratic and Republican voters have contrasting views on health care reform, so not surprisingly, the issue is playing out very differently in the parties' presidential primaries. Democratic and Republican voters have contrasting views on health care reform, so not surprisingly, the issue is playing out very differently in the parties' presidential primaries. tag:odeo.com,2007-11-21,22079037 Wed, 21 Nov 2007 08:00:00 -0800 no NEJM Interviews with PDF http://www.odeo.com/episodes/22017785-NEJM-Interview-Richard-Frank-on-the-ongoing-regulation-of-generic-drugs Richard Frank is a professor of health economics at Harvard Medical School, Boston. Rachel Gotbaum, the interviewer, is an independent producer based in Boston. Supplement to: Frank RG. The Ongoing Regulation of Generic Drugs. N Engl J Med 2007;357(20):1993-6. Richard Frank is a professor of health economics at Harvard Medical School, Boston. Rachel Gotbaum, the interviewer, is an independent producer based in Boston. Supplement to: Frank RG. The Ongoing Regulation of Generic Drugs. N Engl J Med 2007;357(20):1993-6. Richard Frank is a professor of health economics at Harvard Medical School, Boston. Rachel Gotbaum, the interviewer, is an independent producer based in Boston. Supplement to: Frank RG. The Ongoing Regulation of Generic Drugs. N Engl J Med 2007;357(20):1993-6. tag:odeo.com,2007-11-14,22017785 Wed, 14 Nov 2007 08:01:00 -0800 no NEJM Interviews with PDF http://www.odeo.com/episodes/22079038-Perspective-PDF-The-Ongoing-Regulation-of-Generic-Drugs The Hatch–Waxman Act set the rules under which generic pharmaceutical products could compete with brand-name products. Market participants have responded to the regulatory rules in ways that serve their own interests, so Congress has continually reassessed the regulations and sometimes altered the rules to better achieve the law’s original aims. The Hatch–Waxman Act set the rules under which generic pharmaceutical products could compete with brand-name products. Market participants have responded to the regulatory rules in ways that serve their own interests, so Congress has continually reassessed the regulations and sometimes altered the rules to better achieve the law’s original aims. The Hatch–Waxman Act set the rules under which generic pharmaceutical products could compete with brand-name products. Market participants have responded to the regulatory rules in ways that serve their own interests, so Congress has continually reassessed the regulations and sometimes altered the rules to better achieve the law’s original aims. tag:odeo.com,2007-11-14,22079038 Wed, 14 Nov 2007 08:00:00 -0800 no NEJM Interviews with PDF http://www.odeo.com/episodes/22017812-NEJM-Interview-Peter-Orszag-on-the-rising-cost-of-health-care Peter Orszag is the director of the Congressional Budget Office. Rachel Gotbaum, the interviewer, is an independent producer based in Boston. Supplement to: Orszag PR and Ellis P. Addressing Rising Health Care Costs -- A View from the Congressional Budget Office. N Engl J Med 2007;357(19):1885-7. Peter Orszag is the director of the Congressional Budget Office. Rachel Gotbaum, the interviewer, is an independent producer based in Boston. Supplement to: Orszag PR and Ellis P. Addressing Rising Health Care Costs -- A View from the Congressional Budget Office. N Engl J Med 2007;357(19):1885-7. Peter Orszag is the director of the Congressional Budget Office. Rachel Gotbaum, the interviewer, is an independent producer based in Boston. Supplement to: Orszag PR and Ellis P. Addressing Rising Health Care Costs -- A View from the Congressional Budget Office. N Engl J Med 2007;357(19):1885-7. tag:odeo.com,2007-11-07,22017812 Wed, 07 Nov 2007 08:01:00 -0800 no NEJM Interviews with PDF http://www.odeo.com/episodes/22079039-Perspective-PDF-Addressing-Rising-Health-Care-Costs-A-View-from-the-Congressional-Budget-Office A variety of evidence suggests that there are opportunities to constrain health care costs without incurring adverse health consequences. One approach involves generating more information about the relative effectiveness of medical treatments and enhancing the incentives for providers to supply, and consumers to demand, effective care. A variety of evidence suggests that there are opportunities to constrain health care costs without incurring adverse health consequences. One approach involves generating more information about the relative effectiveness of medical treatments and enhancing the incentives for providers to supply, and consumers to demand, effective care. A variety of evidence suggests that there are opportunities to constrain health care costs without incurring adverse health consequences. One approach involves generating more information about the relative effectiveness of medical treatments and enhancing the incentives for providers to supply, and consumers to demand, effective care. tag:odeo.com,2007-11-07,22079039 Wed, 07 Nov 2007 08:00:00 -0800 no NEJM Interviews with PDF http://www.odeo.com/episodes/22017830-NEJM-Interview-Senator-Charles-Grassley-on-President-Bush-s-veto-of-the-SCHIP-reauthorization-bill-and-its-implications Senator Charles Grassley is a Republican from Iowa. Rachel Gotbaum, the interviewer, is an independent producer based in Boston. Supplement to: Iglehart JK. The Fate of SCHIP - Surrogate Marker for Health Care Ideology? N Engl J Med 2007;357. DOI: 10.1056/NEJMp0706881. Senator Charles Grassley is a Republican from Iowa. Rachel Gotbaum, the interviewer, is an independent producer based in Boston. Supplement to: Iglehart JK. The Fate of SCHIP - Surrogate Marker for Health Care Ideology? N Engl J Med 2007;357. DOI: 10.1056/NEJMp0706881. Senator Charles Grassley is a Republican from Iowa. Rachel Gotbaum, the interviewer, is an independent producer based in Boston. Supplement to: Iglehart JK. The Fate of SCHIP - Surrogate Marker for Health Care Ideology? N Engl J Med 2007;357. DOI: 10.1056/NEJMp0706881. tag:odeo.com,2007-10-31,22017830 Wed, 31 Oct 2007 07:01:00 -0700 no NEJM Interviews with PDF